---
figid: PMC4036287__zbc0211482920009
figlink: /pmc/articles/PMC4036287/figure/F9/
number: F9
caption: Working model for Fas signaling in cancer-related inflammation and breast
  cancer progression. Fas ligation induces cell apoptosis of sensitive cells via a
  classical apoptosis signaling pathway (left panel, such as BNL CL.2, etc.). However,
  in Fas signal/apoptosis-resistant cells (such as breast cancer cells, 4T1, or EMT6
  etc.), Fas ligation does not induce apoptosis and instead promotes breast cancer
  cells to produce more IL-6 and PGE2 via activation of the p-p38 and NF-κB pathways,
  which significantly increases systemic (in the peripheral blood and spleen) or local
  (in the tumor microenvironment) recruitment of MDSCs in vivo. In this case MDSCs
  inhibit innate and adaptive immunity and promote tumor growth and metastasis (right).
  Therefore, blockade of Fas signaling can suppress breast cancer progression, indicating
  that Fas signaling-initiated cancer-related inflammation in breast cancer cells
  may be a potential target for treatment of breast cancer.
pmcid: PMC4036287
papertitle: Blockade of Fas Signaling in Breast Cancer Cells Suppresses Tumor Growth
  and Metastasis via Disruption of Fas Signaling-initiated Cancer-related Inflammation.
reftext: Qiuyan Liu, et al. J Biol Chem. 2014 Apr 18;289(16):11522-11535.
pmc_ranked_result_index: '11306'
pathway_score: 0.9278209
filename: zbc0211482920009.jpg
figtitle: Working model for Fas signaling in cancer-related inflammation and breast
  cancer progression
year: '2014'
organisms: Homo sapiens
ndex: ff64ed08-df0b-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4036287__zbc0211482920009.html
  '@type': Dataset
  description: Working model for Fas signaling in cancer-related inflammation and
    breast cancer progression. Fas ligation induces cell apoptosis of sensitive cells
    via a classical apoptosis signaling pathway (left panel, such as BNL CL.2, etc.).
    However, in Fas signal/apoptosis-resistant cells (such as breast cancer cells,
    4T1, or EMT6 etc.), Fas ligation does not induce apoptosis and instead promotes
    breast cancer cells to produce more IL-6 and PGE2 via activation of the p-p38
    and NF-κB pathways, which significantly increases systemic (in the peripheral
    blood and spleen) or local (in the tumor microenvironment) recruitment of MDSCs
    in vivo. In this case MDSCs inhibit innate and adaptive immunity and promote tumor
    growth and metastasis (right). Therefore, blockade of Fas signaling can suppress
    breast cancer progression, indicating that Fas signaling-initiated cancer-related
    inflammation in breast cancer cells may be a potential target for treatment of
    breast cancer.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CASP10
  - CASP8
  - CASP9
  - CS
  - FAS
  - CASP7
  - RELB
  - MAPK14
  - CASP6
  - FADD
  - CASP5
  - IL6
  - MAPK11
  - CASP12
  - REL
  - RELA
  - MAPK13
  - CASP4
  - CASP1
  - CASP2
  - NFKB2
  - TES
  - MAPK12
  - PAFAH1B1
  - NFKB1
  - CASP3
  - CASP14
  - PGE2
genes:
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP10
  entrez: '843'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP8
  entrez: '841'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP9
  entrez: '842'
- word: Cs
  symbol: CS
  source: hgnc_symbol
  hgnc_symbol: CS
  entrez: '1431'
- word: Fas
  symbol: FAS
  source: hgnc_symbol
  hgnc_symbol: FAS
  entrez: '355'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP7
  entrez: '840'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP6
  entrez: '839'
- word: FADD
  symbol: FADD
  source: hgnc_symbol
  hgnc_symbol: FADD
  entrez: '8772'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP5
  entrez: '838'
- word: IL-6
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP12
  entrez: '100506742'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP4
  entrez: '837'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP1
  entrez: '834'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP2
  entrez: '835'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: tes
  symbol: TES
  source: hgnc_symbol
  hgnc_symbol: TES
  entrez: '26136'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: MDS
  symbol: MDS
  source: hgnc_prev_symbol
  hgnc_symbol: PAFAH1B1
  entrez: '5048'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP3
  entrez: '836'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP14
  entrez: '23581'
chemicals:
- word: PGE2
  source: MESH
  identifier: D015232
diseases: []
figid_alias: PMC4036287__F9
redirect_from: /figures/PMC4036287__F9
figtype: Figure
---
